Roberto Freilone

5PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2025
Mechanisms of Resistance to CAR T-Cells and How to Overcome Them.

Luca Legato, Matteo Bisio, Filippo Fasano

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio

|Jan 11, 2025
Bispecific Antibodies for Lymphoid Malignancy Treatment.

Matteo Bisio, Luca Legato, Filippo Fasano

|Mar 15, 2023
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.

Chiara Frairia, Barbara Nicolino, Carolina Secreto

Pageof 1

Frequent Collaborators

2 joint publications

Barbara Botto

2 joint publications

Alessandro Busca

2 joint publications

Marco Cerrano

2 joint publications

Mattia Novo